$ARCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcturus Therapeutics Holdings Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Arcturus Therapeutics Holdings Inc.. Get notifications about new insider transactions in Arcturus Therapeutics Holdings Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 03 2021 | ARCT | Arcturus Therapeut ... | Chivukula Pad | Chief Scientific Of ... | Sell | S | 75.31 | 10,000 | 753,100 | 672,548 | 682.5 K to 672.5 K (-1.47 %) |
Feb 03 2021 | ARCT | Arcturus Therapeut ... | Chivukula Pad | Chief Scientific Of ... | Sell | S | 75.31 | 10,000 | 753,100 | 672,548 | 682.5 K to 672.5 K (-1.47 %) |
Dec 22 2020 | ARCT | Arcturus Therapeut ... | Kummerfeld Keith C | See Remarks | Option Exercise | A | 99.29 | 45,000 | 4,468,050 | 45,000 | |
Dec 22 2020 | ARCT | Arcturus Therapeut ... | Chivukula Pad | Chief Scientific Of ... | Option Exercise | A | 99.29 | 100,000 | 9,929,000 | 100,000 | |
Dec 22 2020 | ARCT | Arcturus Therapeut ... | Payne Joseph E | President and CEO | Option Exercise | A | 99.29 | 175,000 | 17,375,750 | 175,000 | |
Dec 22 2020 | ARCT | Arcturus Therapeut ... | SASSINE ANDY | Chief Financial Off ... | Option Exercise | A | 99.29 | 100,000 | 9,929,000 | 100,000 | |
Dec 22 2020 | ARCT | Arcturus Therapeut ... | Hughes Steven George | Chief Development O ... | Option Exercise | A | 99.29 | 50,000 | 4,964,500 | 50,000 | |
Dec 22 2020 | ARCT | Arcturus Therapeut ... | Kurata Lance | Chief Legal Officer | Option Exercise | A | 99.29 | 25,000 | 2,482,250 | 25,000 | |
Dec 10 2020 | ARCT | Arcturus Therapeut ... | Ultragenyx Pharmaceutical Inc. | Director | Sell | S | 94.97 | 357,745 | 33,975,043 | 2,200,000 | 2.6 M to 2.2 M (-13.99 %) |
Dec 10 2020 | ARCT | Arcturus Therapeut ... | Ultragenyx Pharmaceutical Inc. | Director | Sell | S | 105.54 | 442,255 | 46,675,593 | 2,557,745 | 3 M to 2.6 M (-14.74 %) |
Dec 03 2020 | ARCT | Arcturus Therapeut ... | Chivukula Pad | Chief Scientific Of ... | Sell | S | 96.19 | 10,000 | 961,900 | 692,548 | 702.5 K to 692.5 K (-1.42 %) |
Sep 04 2020 | ARCT | Arcturus Therapeut ... | Chivukula Pad | Chief Scientific Of ... | Sell | S | 45.16 | 10,000 | 451,600 | 722,548 | 732.5 K to 722.5 K (-1.37 %) |
Aug 12 2020 | ARCT | Arcturus Therapeut ... | Kurata Lance | Chief Legal Officer | Option Exercise | A | 58.91 | 90,000 | 5,301,900 | 90,000 | |
Jun 24 2020 | ARCT | Arcturus Therapeut ... | Parschauer Karah Herdman | Director | Option Exercise | A | 40.70 | 15,000 | 610,500 | 15,000 | |
Jun 24 2020 | ARCT | Arcturus Therapeut ... | Marquet Magda | Director | Option Exercise | A | 40.70 | 15,000 | 610,500 | 15,000 | |
Jun 24 2020 | ARCT | Arcturus Therapeut ... | HOLMES EDWARD W | Director | Option Exercise | A | 40.70 | 15,000 | 610,500 | 15,000 | |
Jun 24 2020 | ARCT | Arcturus Therapeut ... | BARLOW JAMES F | Director | Option Exercise | A | 40.70 | 15,000 | 610,500 | 15,000 | |
Jun 24 2020 | ARCT | Arcturus Therapeut ... | FARRELL PETER C | Director | Option Exercise | A | 40.70 | 15,000 | 610,500 | 15,000 | |
Jun 12 2020 | ARCT | Arcturus Therapeut ... | Kummerfeld Keith C | See Remarks | Buy | P | 33.33 | 450 | 14,999 | 950 | 500 to 950 (+90.00 %) |
Jun 10 2020 | ARCT | Arcturus Therapeut ... | Payne Joseph E | President and CEO | Buy | P | 31.69 | 1,000 | 31,690 | 1,475,097 | 1.5 M to 1.5 M (+0.07 %) |
Jun 10 2020 | ARCT | Arcturus Therapeut ... | Payne Joseph E | President and CEO | Buy | P | 31.69 | 1,000 | 31,690 | 1,475,097 | 1.5 M to 1.5 M (+0.07 %) |
Jun 10 2020 | ARCT | Arcturus Therapeut ... | SASSINE ANDY | Chief Financial Off ... | Buy | P | 29.74 | 5,000 | 148,700 | 273,245 | 268.2 K to 273.2 K (+1.86 %) |
Jun 10 2020 | ARCT | Arcturus Therapeut ... | SASSINE ANDY | Chief Financial Off ... | Buy | P | 29.74 | 5,000 | 148,700 | 273,245 | 268.2 K to 273.2 K (+1.86 %) |
May 22 2020 | ARCT | Arcturus Therapeut ... | Ultragenyx Pharmaceutical Inc. | Director | Option Exercise | M | 16.00 | 600,000 | 9,600,000 | 0 | |
May 22 2020 | ARCT | Arcturus Therapeut ... | Ultragenyx Pharmaceutical Inc. | Director | Buy | M | 16.00 | 600,000 | 9,600,000 | 3,000,000 | 2.4 M to 3 M (+25.00 %) |
Feb 20 2020 | ARCT | Arcturus Therapeut ... | Chivukula Pad | Chief Scientific Of ... | Option Exercise | A | 14.12 | 60,000 | 847,200 | 60,000 | |
Feb 20 2020 | ARCT | Arcturus Therapeut ... | Kummerfeld Keith C | See Remarks | Option Exercise | A | 14.12 | 10,000 | 141,200 | 10,000 | |
Feb 20 2020 | ARCT | Arcturus Therapeut ... | Hughes Steven George | Chief Development O ... | Option Exercise | A | 14.12 | 75,000 | 1,059,000 | 75,000 | |
Feb 20 2020 | ARCT | Arcturus Therapeut ... | SASSINE ANDY | Chief Financial Off ... | Option Exercise | A | 14.12 | 80,000 | 1,129,600 | 80,000 | |
Feb 20 2020 | ARCT | Arcturus Therapeut ... | Payne Joseph E | President and CEO | Option Exercise | A | 14.12 | 100,000 | 1,412,000 | 100,000 | |
Dec 09 2019 | ARCT | Arcturus Therapeut ... | SASSINE ANDY | Chief Financial Off ... | Buy | P | 9.73 | 5,649 | 54,965 | 268,245 | 262.6 K to 268.2 K (+2.15 %) |
Dec 09 2019 | ARCT | Arcturus Therapeut ... | SASSINE ANDY | Chief Financial Off ... | Buy | P | 9.73 | 5,649 | 54,965 | 268,245 | 262.6 K to 268.2 K (+2.15 %) |
Dec 05 2019 | ARCT | Arcturus Therapeut ... | SASSINE ANDY | Chief Financial Off ... | Buy | P | 10.00 | 10,000 | 100,000 | 257,596 | 247.6 K to 257.6 K (+4.04 %) |
Oct 29 2019 | ARCT | Arcturus Therapeut ... | BARLOW JAMES F | Director | Option Exercise | A | 10.23 | 15,000 | 153,450 | 15,000 | |
Oct 29 2019 | ARCT | Arcturus Therapeut ... | Parschauer Karah Herdman | Director | Option Exercise | A | 10.23 | 20,000 | 204,600 | 20,000 | |
Oct 29 2019 | ARCT | Arcturus Therapeut ... | Parschauer Karah Herdman | Director | Option Exercise | A | 10.23 | 15,000 | 153,450 | 15,000 | |
Oct 29 2019 | ARCT | Arcturus Therapeut ... | HOLMES EDWARD W | Director | Option Exercise | A | 10.23 | 20,000 | 204,600 | 20,000 | |
Oct 29 2019 | ARCT | Arcturus Therapeut ... | HOLMES EDWARD W | Director | Option Exercise | A | 10.23 | 15,000 | 153,450 | 15,000 | |
Oct 29 2019 | ARCT | Arcturus Therapeut ... | Marquet Magda | Director | Option Exercise | A | 10.23 | 15,000 | 153,450 | 15,000 | |
Oct 29 2019 | ARCT | Arcturus Therapeut ... | FARRELL PETER C | Director | Option Exercise | A | 10.23 | 15,000 | 153,450 | 15,000 | |
Sep 17 2019 | ARCT | Arcturus Therapeut ... | Marquet Magda | Director | Buy | P | 10.58 | 2,300 | 24,334 | 22,720 | 20.4 K to 22.7 K (+11.26 %) |
Sep 17 2019 | ARCT | Arcturus Therapeut ... | Marquet Magda | Director | Buy | P | 10.58 | 2,300 | 24,334 | 22,720 | 20.4 K to 22.7 K (+11.26 %) |
Sep 12 2019 | ARCT | Arcturus Therapeut ... | Kummerfeld Keith C | See Remarks | Buy | P | 10.69 | 500 | 5,347 | 500 | 0 to 500 |
Sep 12 2019 | ARCT | Arcturus Therapeut ... | Kummerfeld Keith C | See Remarks | Buy | P | 10.69 | 500 | 5,347 | 500 | 0 to 500 |
Aug 30 2019 | ARCT | Arcturus Therapeut ... | Payne Joseph E | President and CEO | Buy | P | 11.22 | 5,000 | 56,100 | 1,474,097 | 1.5 M to 1.5 M (+0.34 %) |
Aug 26 2019 | ARCT | Arcturus Therapeut ... | SASSINE ANDY | Chief Financial Off ... | Buy | P | 10.90 | 10,000 | 109,000 | 247,596 | 237.6 K to 247.6 K (+4.21 %) |
Aug 21 2019 | ARCT | Arcturus Therapeut ... | FARRELL PETER C | Director | Buy | P | 10.85 | 4,432 | 48,087 | 42,955 | 38.5 K to 43 K (+11.50 %) |
Aug 21 2019 | ARCT | Arcturus Therapeut ... | FARRELL PETER C | Director | Buy | P | 10.85 | 4,432 | 48,087 | 42,955 | 38.5 K to 43 K (+11.50 %) |
Aug 21 2019 | ARCT | Arcturus Therapeut ... | FARRELL PETER C | Director | Buy | P | 11.02 | 4,681 | 51,585 | 38,523 | 33.8 K to 38.5 K (+13.83 %) |
Aug 21 2019 | ARCT | Arcturus Therapeut ... | FARRELL PETER C | Director | Buy | P | 11.02 | 4,681 | 51,585 | 38,523 | 33.8 K to 38.5 K (+13.83 %) |
Page: 1